Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

144 trials with published results (23%)

Research Maturity

302 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

3.9%

25 terminated out of 634 trials

Success Rate

92.4%

+5.8% vs benchmark

Late-Stage Pipeline

6%

36 trials in Phase 3/4

Results Transparency

48%

144 of 302 completed with results

Key Signals

144 with results92% success25 terminated

Data Visualizations

Phase Distribution

574Total
Not Applicable (338)
Early P 1 (16)
P 1 (51)
P 2 (133)
P 3 (15)
P 4 (21)

Trial Status

Completed302
Recruiting148
Unknown42
Not Yet Recruiting41
Active Not Recruiting41
Terminated25

Trial Success Rate

92.4%

Benchmark: 86.5%

Based on 302 completed trials

Clinical Trials (634)

Showing 20 of 20 trials
NCT07191561RecruitingPrimary

Hepatic Lipid Metabolism-Alcohol Use Disorder

NCT06860607Phase 1RecruitingPrimary

Environment and Alcohol: A Pilot Study

NCT06305624Not ApplicableRecruitingPrimary

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

NCT06790342Phase 3Not Yet Recruiting

Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya

NCT04523922Phase 2Completed

Oxytocin to Enhance Integrated Treatment for AUD and PTSD

NCT07728968Not ApplicableActive Not Recruiting

The 15-Mental Project: Implementation and Evaluation of the 15-Mental in a Mental Health Hospital Setting

NCT05607290Not ApplicableActive Not RecruitingPrimary

Clinical Course of Alcohol Use Disorder Recovery

NCT06015893Phase 2Active Not Recruiting

Semaglutide Therapy for Alcohol Reduction (STAR)

NCT07678567Not Yet RecruitingPrimary

Pomegranate Dietary Supplements in AUD and ALD

NCT07724275Not ApplicableRecruitingPrimary

Understanding Pathways to Wellness and Recovery in Detroit - Digital Recovery Support Services

NCT07218354Phase 3Not Yet RecruitingPrimary

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder

NCT07046819Phase 2Recruiting

Tirzepatide in MetALD

NCT06552741Recruiting

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

NCT06269627Phase 4RecruitingPrimary

Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder

NCT05807139Phase 1RecruitingPrimary

Spironolactone in Alcohol Use Disorder (SAUD)

NCT07219953Phase 3RecruitingPrimary

A Study of Brenipatide in Participants With Alcohol Use Disorder

NCT05827159Phase 3RecruitingPrimary

Emergency Department-Initiated Medications for Alcohol Use Disorder

NCT07219966Phase 3RecruitingPrimary

A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder

NCT07713251Not ApplicableRecruitingPrimary

Supporting Adolescent Alcohol Treatment With Computer-Based ('Path180') Skills Training

NCT07216872Not ApplicableRecruitingPrimary

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)

Scroll to load more

Research Network

Activity Timeline